Literature DB >> 6352097

Insulitis as a consequence of immune dysregulation: further evidence.

K Flohr, U Kiesel, G Freytag, H Kolb.   

Abstract

Lymphocytic infiltrations in pancreatic islets (insulitis) have been shown previously to occur in mice with spontaneous or experimentally induced immune disorders. We now have studied which type of immune dysregulation leads to insulitis. Immune disorders were induced by treatment with cyclophosphamide (Cy) or phenytoin and by graft versus host reactions (GVHR) across minor or major histocompatibility barriers. Histological analysis of immune disturbed animals revealed insulitis after phenytoin treatment and as a consequence of GVHR. Insulitis during GVHR is only observed in certain mouse strain combinations. Treatment with Cy in a large dose range does not lead to lymphocytic infiltration of pancreatic islets. It is concluded that cellular immunity to islet cells can occur spontaneously during certain types of immune dysregulation. Since phenytoin treatment and GVHR stimulate lymphocytes reactive with major histocompatibility antigens, such structures may also be part of target antigens on islet cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352097      PMCID: PMC1535659     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Genetic susceptibility to post-thymectomy autoimmune diseases in mice.

Authors:  A Kojima; R T Prehn
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

2.  Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium.

Authors:  D W Mason; M Dallman; A N Barclay
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

3.  Animal model of human disease. Lymphocytic thyroiditis. Autoimmune thyroiditis in rats induced by thymectomy and irradiation.

Authors:  W J Penhale; S A Ahmed
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

4.  Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease.

Authors:  H Kolb; G Freytag; U Kiesel; V Kolb-Bachofen
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

5.  Experimental autoimmune orchitis after neonatal thymectomy in the mouse.

Authors:  O Taguchi; Y Nishizuka
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus.

Authors:  M Horita; H Suzuki; T Onodera; F Ginsberg-Fellner; A S Fauci; A L Notkins
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

7.  Defective suppressor cell generation in juvenile onset diabetes.

Authors:  M M Lederman; J J Ellner; H M Rodman
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Capacity of genetically different T lymphocytes to induce lethal graft-versus-host disease correlates with their capacity to generate suppression but not with their capacity to generate anti-F1 killer cells. A non-H-2 locus determines the inability to induce lethal graft-versus-host disease.

Authors:  E H Van Elven; A G Rolink; F V Veen; E Gleichmann
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

9.  Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease.

Authors:  A G Rolink; T Radaszkiewicz; S T Pals; W G van der Meer; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

10.  Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T-B cell cooperation across I-E.

Authors:  F M van Rappard-van der Veen; A G Rolink; E Gleichmann
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  2 in total

1.  A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Authors:  Jamal S Lewis; Natalia V Dolgova; Ying Zhang; Chang Qing Xia; Clive H Wasserfall; Mark A Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Clin Immunol       Date:  2015-04-02       Impact factor: 3.969

2.  Prevalence of ZnT8 Antibody in Turkish Children and Adolescents with New Onset Type 1 Diabetes

Authors:  Selin Elmaoğulları; Seyit Ahmet Uçaktürk; Şehri Elbeg; Esra Döğer; Meltem Tayfun; Fatih Gürbüz; Aysun Bideci
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.